HSPA9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.303800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.687900E-02
Normal-vs-Stage2
3.229600E-01
Normal-vs-Stage3
7.548000E-01
Normal-vs-Stage4
1.692360E-01
Stage1-vs-Stage2
9.201800E-02
Stage1-vs-Stage3
2.300300E-02
Stage1-vs-Stage4
4.824000E-01
Stage2-vs-Stage3
1.457990E-01
Stage2-vs-Stage4
5.456600E-01
Stage3-vs-Stage4
1.276180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.353800E-01
Normal-vs-AfricanAmerican
2.097800E-01
Normal-vs-Asian
4.502400E-01
Caucasian-vs-AfricanAmerican
9.240600E-01
Caucasian-vs-Asian
8.720400E-01
AfricanAmerican-vs-Asian
8.584600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.502400E-01
Normal-vs-Female
3.075000E-01
Male-vs-Female
9.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.124600E-01
Normal-vs-Age(41-60Yrs)
1.537000E-01
Normal-vs-Age(61-80Yrs)
4.644200E-01
Normal-vs-Age(81-100Yrs)
3.589800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.169800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.451000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.774200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.518600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.380620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.677800E-01
Normal-vs-Daily Drinker
2.902200E-01
Normal-vs-Weekly Drinker
3.945800E-01
Normal-vs-Occasional Drinker
2.151000E-01
Normal-vs-Social Drinker
2.872600E-01
Non Drinker-vs-Daily Drinker
2.820800E-01
Non Drinker-vs-Weekly Drinker
5.413400E-01
Non Drinker-vs-Occasional Drinker
8.977600E-02
Non Drinker-vs-Social Drinker
1.016950E-01
Daily Drinker-vs-Weekly Drinker
7.625000E-01
Daily Drinker-vs-Occasional Drinker
4.788200E-01
Daily Drinker-vs-Social Drinker
4.397600E-01
Weekly Drinker-vs-Occasional Drinker
3.814400E-01
Weekly Drinker-vs-Social Drinker
3.804000E-01
Occasional Drinker-vs-Social Drinker
8.776000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.477800E-01
Normal-vs-Grade 2
7.672400E-01
Normal-vs-Grade 3
7.592400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.581200E-01
Grade 1-vs-Grade 3
7.201600E-01
Grade 1-vs-Grade 4
5.477800E-01
Grade 2-vs-Grade 3
8.668800E-01
Grade 2-vs-Grade 4
7.672400E-01
Grade 3-vs-Grade 4
7.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.268800E-01
Normal-vs-NonDiabetic
3.294200E-01
Diabetic-vs-NonDiabetic
2.767000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.575700E-02
Normal-vs-NoPancreatitis
3.713200E-01
Pancreatitis-vs-NoPancreatitis
5.274200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.024000E-01
Normal-vs-N1
3.620200E-01
N0-vs-N1
1.658610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.050360E-01
Normal-vs-TP53-NonMutant
1.383530E-02
TP53-Mutant-vs-TP53-NonMutant
3.430000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
